Luye Pharma Group Ltd. (LYPHF)
OTHER OTC:LYPHF
Holding LYPHF?
Track your performance easily

Luye Pharma Group (LYPHF) Financial Statements

3 Followers

Luye Pharma Group Financial Overview

Luye Pharma Group's market cap is currently ―. The company's EPS TTM is $0.028; its P/E ratio is 12.69; Luye Pharma Group is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 5.57B¥ 5.51B¥ 6.34B¥ 5.41B¥ 5.36B
Total Assets¥ 22.57B¥ 22.58B¥ 21.84B¥ 20.63B¥ 19.56B
Total Debt¥ 9.19B¥ 9.49B¥ 8.91B¥ 9.98B¥ 8.99B
Net Debt¥ 3.62B¥ 3.98B¥ 2.56B¥ 4.58B¥ 3.63B
Total Liabilities¥ 13.12B¥ 13.47B¥ 12.15B¥ 12.53B¥ 11.74B
Stockholders Equity¥ 8.81B¥ 8.49B¥ 9.14B¥ 7.89B¥ 7.67B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Luye Pharma Group Earnings and Revenue History

Luye Pharma Group Debt to Assets

Luye Pharma Group Cash Flow

Luye Pharma Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis